The anti-apoptotic activity associated with phosphatidylinositol transfer protein α activates the MAPK and Akt/PKB pathway

Biochimica et Biophysica Acta - Molecular Cell Research

Volumn 1783, Issue 10, 2008, Pages 1700-1706

  Schenning, Martijn ^a   Goedhart, Joachim ^b   Gadella Jr , Theodorus W J ^b   Avram, Diana ^a   Wirtz, Karel W A ^a   Snoek, Gerry T ^a  

^a UTRECHT UNIVERSITY   (Netherlands)

^b UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

Apoptosis; NF B; p42 p44 MAPK; Phospholipase C; PI TP ; PI TP

Indexed keywords

CANNABINOID 1 RECEPTOR; CARRIER PROTEIN; G PROTEIN COUPLED RECEPTOR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 14; MITOGEN ACTIVATED PROTEIN KINASE 3; PERTUSSIS TOXIN; PHOSPHATIDYLINOSITOL TRANSFER PROTEIN ALPHA; PHOSPHOLIPASE C; PROTEIN KINASE B; PROTEIN KINASE C; RIMONABANT; UNCLASSIFIED DRUG;

ANIMAL CELL; APOPTOSIS; ARTICLE; CELL CULTURE; CELL GROWTH; CELL MEMBRANE; CELL NUCLEUS; CELL STRAIN 3T3; CONFOCAL LASER MICROSCOPY; CONTROLLED STUDY; CULTURE MEDIUM; ENZYME ACTIVATION; ENZYME ACTIVITY; FIBROBLAST; FLUORESCENCE MICROSCOPY; FUNCTIONAL PROTEOMICS; GROWTH REGULATION; INCUBATION TIME; METABOLISM; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PROTEIN TRANSPORT; RADIATION EXPOSURE; SIGNAL TRANSDUCTION; ULTRAVIOLET IRRADIATION; WESTERN BLOTTING;

ANIMALS; APOPTOSIS; CELL MEMBRANE; ENZYME ACTIVATION; MAP KINASE SIGNALING SYSTEM; MICE; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; NF-KAPPA B; NIH 3T3 CELLS; PHOSPHOLIPID TRANSFER PROTEINS; PHOSPHORYLATION; PROTO-ONCOGENE PROTEINS C-AKT; RECEPTOR, CANNABINOID, CB1; TYPE C PHOSPHOLIPASES;

GADELLA;

EID: 50849099482     PISSN: 01674889     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbamcr.2008.04.014     Document Type: Article

References (70)

1. Schenning M., van Tiel C.M., Van Manen D., Stam J.C., Gadella B.M., Wirtz K.W., and Snoek G.T. Phosphatidylinositol transfer protein alpha regulates growth and apoptosis of NIH3T3 cells: involvement of a cannabinoid 1-like receptor. J. Lipid Res. 45 (2004) 1555-1564
2. Wirtz K.W. Phospholipid transfer proteins. Annu. Rev. Biochem. 60 (1991) 73-99
3. Wirtz K.W. Phospholipid transfer proteins revisited. Biochem. J. 324 Pt 2 (1997) 353-360
4. Tanaka S., and Hosaka K. Cloning of a cDNA encoding a second phosphatidylinositol transfer protein of rat brain by complementation of the yeast sec14 mutation. J. Biochem. (Tokyo) 115 (1994) 981-984
5. De Vries K.J., Westerman J., Bastiaens P.I., Jovin T.M., Wirtz K.W., and Snoek G.T. Fluorescently labeled phosphatidylinositol transfer protein isoforms (alpha and beta), microinjected into fetal bovine heart endothelial cells, are targeted to distinct intracellular sites. Exp. Cell Res. 227 (1996) 33-39
6. Morgan C.P., Allen-Baume V., Radulovic M., Li M., Skippen A., and Cockcroft S. Differential expression of a C-terminal splice variant of phosphatidylinositol transfer protein beta lacking the constitutive-phosphorylated Ser262 that localizes to the Golgi compartment. Biochem. J. 398 (2006) 411-421
7. Phillips S.E., Ile K.E., Boukhelifa M., Huijbregts R.P., and Bankaitis V.A. Specific and nonspecific membrane-binding determinants cooperate in targeting phosphatidylinositol transfer protein beta-isoform to the mammalian trans-Golgi network. Mol. Biol. Cell 17 (2006) 2498-2512
8. Ohashi M., Jan de Vries K., Frank R., Snoek G., Bankaitis V., Wirtz K., and Huttner W.B. A role for phosphatidylinositol transfer protein in secretory vesicle formation. Nature 377 (1995) 544-547
9. Monaco M.E., Alexander R.J., Snoek G.T., Moldover N.H., Wirtz K.W., and Walden P.D. Evidence that mammalian phosphatidylinositol transfer protein regulates phosphatidylcholine metabolism. Biochem. J. 335 Pt 1 (1998) 175-179
10. Snoek G.T., Berrie C.P., Geijtenbeek T.B., van der Helm H.A., Cadee J.A., Iurisci C., Corda D., and Wirtz K.W. Overexpression of phosphatidylinositol transfer protein alpha in NIH3T3 cells activates a phospholipase A. J. Biol. Chem. 274 (1999) 35393-35399
11. Thomas G.M., Cunningham E., Fensome A., Ball A., Totty N.F., Truong O., Hsuan J.J., and Cockcroft S. An essential role for phosphatidylinositol transfer protein in phospholipase C-mediated inositol lipid signaling. Cell 74 (1993) 919-928
12. Chalimoniuk M., Snoek G.T., Adamczyk A., Malecki A., and Strosznajder J.B. Phosphatidylinositol transfer protein expression altered by aging and Parkinson disease. Cell. Mol. Neurobiol. 26 (2006) 1153-1166
13. Alb Jr. J.G., Cortese J.D., Phillips S.E., Albin R.L., Nagy T.R., Hamilton B.A., and Bankaitis V.A. Mice lacking phosphatidylinositol transfer protein-alpha exhibit spinocerebellar degeneration, intestinal and hepatic steatosis, and hypoglycemia. J. Biol. Chem. 278 (2003) 33501-33518
14. Hamilton B.A., Smith D.J., Mueller K.L., Kerrebrock A.W., Bronson R.T., van Berkel V., Daly M.J., Kruglyak L., Reeve M.P., Nemhauser J.L., Hawkins T.L., Rubin E.M., and Lander E.S. The vibrator mutation causes neurodegeneration via reduced expression of PITP alpha: positional complementation cloning and extragenic suppression. Neuron 18 (1997) 711-722
15. Ozaita A., Puighermanal E., and Maldonado R. Regulation of PI3K/Akt/GSK-3 pathway by cannabinoids in the brain. J. Neurochem. 102 (2007) 1105-1114
16. Bonni A., Brunet A., West A.E., Datta S.R., Takasu M.A., and Greenberg M.E. Cell survival promoted by the Ras-MAPK signaling pathway by transcription-dependent and -independent mechanisms. Science 286 (1999) 1358-1362
17. Hetman M., Kanning K., Cavanaugh J.E., and Xia Z. Neuroprotection by brain-derived neurotrophic factor is mediated by extracellular signal-regulated kinase and phosphatidylinositol 3-kinase. J. Biol. Chem. 274 (1999) 22569-22580
18. Holmstrom T.H., Schmitz I., Soderstrom T.S., Poukkula M., Johnson V.L., Chow S.C., Krammer P.H., and Eriksson J.E. MAPK/ERK signaling in activated T cells inhibits CD95/Fas-mediated apoptosis downstream of DISC assembly. EMBO J. 19 (2000) 5418-5428
19. Lewis T.S., Shapiro P.S., and Ahn N.G. Signal transduction through MAP kinase cascades. Adv. Cancer Res. 74 (1998) 49-139
20. Cobb M.H. MAP kinase pathways. Prog. Biophys. Mol. Biol. 71 (1999) 479-500
21. Johnson G.L., and Vaillancourt R.R. Sequential protein kinase reactions controlling cell growth and differentiation. Curr. Opin. Cell Biol. 6 (1994) 230-238
22. Gille H., Sharrocks A.D., and Shaw P.E. Phosphorylation of transcription factor p62TCF by MAP kinase stimulates ternary complex formation at c-fos promoter. Nature 358 (1992) 414-417
23. Marais R., Wynne J., and Treisman R. The SRF accessory protein Elk-1 contains a growth factor-regulated transcriptional activation domain. Cell 73 (1993) 381-393
24. Fukuda M., Gotoh I., Adachi M., Gotoh Y., and Nishida E. A novel regulatory mechanism in the mitogen-activated protein (MAP) kinase cascade. Role of nuclear export signal of MAP kinase kinase. J. Biol. Chem. 272 (1997) 32642-32648
25. Tashker J.S., Olson M., and Kornbluth S. Post-cytochrome C protection from apoptosis conferred by a MAPK pathway in Xenopus egg extracts. Mol. Biol. Cell 13 (2002) 393-401
26. Erhardt P., Schremser E.J., and Cooper G.M. B-Raf inhibits programmed cell death downstream of cytochrome c release from mitochondria by activating the MEK/Erk pathway. Mol. Cell. Biol. 19 (1999) 5308-5315
27. Jiang B., Brecher P., and Cohen R.A. Persistent activation of nuclear factor-kappaB by interleukin-1beta and subsequent inducible NO synthase expression requires extracellular signal-regulated kinase. Arterioscler. Thromb. Vasc. Biol. 21 (2001) 1915-1920
28. Brazil D.P., and Hemmings B.A. Ten years of protein kinase B signalling: a hard Akt to follow. Trends Biochem. Sci. 26 (2001) 657-664
29. Wymann M.P., Zvelebil M., and Laffargue M. Phosphoinositide 3-kinase signalling-which way to target?. Trends Pharmacol. Sci. 24 (2003) 366-376
30. Sable C.L., Filippa N., Hemmings B., and Van Obberghen E. cAMP stimulates protein kinase B in a Wortmannin-insensitive manner. FEBS Lett. 409 (1997) 253-257
31. Filippa N., Sable C.L., Filloux C., Hemmings B., and Van Obberghen E. Mechanism of protein kinase B activation by cyclic AMP-dependent protein kinase. Mol. Cell. Biol. 19 (1999) 4989-5000
32. Kane L.P., Shapiro V.S., Stokoe D., and Weiss A. Induction of NF-kappaB by the Akt/PKB kinase. Curr. Biol. 9 (1999) 601-604
33. Factor V., Oliver A.L., Panta G.R., Thorgeirsson S.S., Sonenshein G.E., and Arsura M. Roles of Akt/PKB and IKK complex in constitutive induction of NF-kappaB in hepatocellular carcinomas of transforming growth factor alpha/c-myc transgenic mice. Hepatology 34 (2001) 32-41
34. Du K., and Montminy M. CREB is a regulatory target for the protein kinase Akt/PKB. J. Biol. Chem. 273 (1998) 32377-32379
35. Burgering B.M., and Medema R.H. Decisions on life and death: FOXO Forkhead transcription factors are in command when PKB/Akt is off duty. J. Leukoc. Biol. 73 (2003) 689-701
36. Basu S., Totty N.F., Irwin M.S., Sudol M., and Downward J. Akt phosphorylates the Yes-associated protein, YAP, to induce interaction with 14-3-3 and attenuation of p73-mediated apoptosis. Mol. Cell 11 (2003) 11-23
37. Van Tiel C.M., Luberto C., Snoek G.T., Hannun Y.A., and Wirtz K.W. Rapid replenishment of sphingomyelin in the plasma membrane upon degradation by sphingomyelinase in NIH3T3 cells overexpressing the phosphatidylinositol transfer protein beta. Biochem. J. 346 Pt 2 (2000) 537-543
38. Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72 (1976) 248-254
39. Channon J.Y., Miselis K.A., Minns L.A., Dutta C., and Kasper L.H. Toxoplasma gondii induces granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor secretion by human fibroblasts: implications for neutrophil apoptosis. Infect. Immun. 70 (2002) 6048-6057
40. Chang L., Crowston J.G., Sabin C.A., Khaw P.T., and Akbar A.N. Human tenon's fibroblast-produced ifnbeta and the prevention of t-cell apoptosis. Invest. Ophthalmol. Vis. Sci. 42 (2001) 1531-1538
41. Egertova M., and Elphick M.R. Localisation of cannabinoid receptors in the rat brain using antibodies to the intracellular C-terminal tail of CB. J. Comp. Neurol. 422 (2000) 159-171
42. Farquhar-Smith W.P., Egertova M., Bradbury E.J., McMahon S.B., Rice A.S., and Elphick M.R. Cannabinoid CB(1) receptor expression in rat spinal cord. Mol. Cell. Neurosci. 15 (2000) 510-521
43. Song C., and Howlett A.C. Rat brain cannabinoid receptors are N-linked glycosylated proteins. Life Sci. 56 (1995) 1983-1989
44. Shire D., Carillon C., Kaghad M., Calandra B., Rinaldi-Carmona M., Le Fur G., Caput D., and Ferrara P. An amino-terminal variant of the central cannabinoid receptor resulting from alternative splicing. J. Biol. Chem. 270 (1995) 3726-3731
45. Andersson H., D'Antona A.M., Kendall D.A., Von Heijne G., and Chin C.N. Membrane assembly of the cannabinoid receptor 1: impact of a long N-terminal tail. Mol. Pharmacol. 64 (2003) 570-577
46. Howlett A.C. Cannabinoid receptor signaling. Handb. Exp. Pharmacol. (2005) 53-79
47. Horgan A.M., and Stork P.J. Examining the mechanism of Erk nuclear translocation using green fluorescent protein. Exp. Cell Res. 285 (2003) 208-220
48. Burack W.R., and Shaw A.S. Live Cell Imaging of ERK and MEK: simple binding equilibrium explains the regulated nucleocytoplasmic distribution of ERK. J. Biol. Chem. 280 (2005) 3832-3837
49. Teruel M.N., and Meyer T. Parallel single-cell monitoring of receptor-triggered membrane translocation of a calcium-sensing protein module. Science 295 (2002) 1910-1912
50. Schultz C., Schleifenbaum A., Goedhart J., and Gadella Jr. T.W. Multiparameter imaging for the analysis of intracellular signaling. Chembiochem 6 (2005) 1323-1330
51. Lauckner J.E., Hille B., and Mackie K. The cannabinoid agonist WIN55,212-2 increases intracellular calcium via CB1 receptor coupling to Gq/11 G proteins. Proc. Natl. Acad. Sci. U. S. A. 102 (2005) 19144-19149
52. Bunte H., Schenning M., Sodaar P., Bar D.P., Wirtz K.W., van Muiswinkel F.L., and Snoek G.T. A phosphatidylinositol transfer protein alpha-dependent survival factor protects cultured primary neurons against serum deprivation-induced cell death. J. Neurochem. 97 (2006) 707-715
53. Ryberg E., Vu H.K., Larsson N., Groblewski T., Hjorth S., Elebring T., Sjogren S., and Greasley P.J. Identification and characterisation of a novel splice variant of the human CB1 receptor. FEBS Lett. 579 (2005) 259-264
54. Nordstrom R., and Andersson H. Amino-terminal processing of the human cannabinoid receptor 1. J. Recept. Signal Transduct. Res. 26 (2006) 259-267
55. Schenning M., van Tiel C.M., Wirtz K.W., and Snoek G.T. The anti-apoptotic MAP kinase pathway is inhibited in NIH3T3 fibroblasts with increased expression of phosphatidylinositol transfer protein beta. Biochim. Biophys. Acta 1773 (2007) 1664-1671
56. van Tiel C.M., Schenning M., Snoek G.T., and Wirtz K.W. Overexpression of phosphatidylinositol transfer protein beta in NIH3T3 cells has a stimulatory effect on sphingomyelin synthesis and apoptosis. Biochim. Biophys. Acta 1636 (2004) 151-158
57. Teixeira-Clerc F., Julien B., Grenard P., Tran Van Nhieu J., Deveaux V., Li L., Serriere-Lanneau V., Ledent C., Mallat A., and Lotersztajn S. CB1 cannabinoid receptor antagonism: a new strategy for the treatment of liver fibrosis. Nat. Med. 12 (2006) 671-676
58. Guzman M., Sanchez C., and Galve-Roperh I. Control of the cell survival/death decision by cannabinoids. J. Mol. Med. 78 (2001) 613-625
59. Gomez del Pulgar T., Velasco G., and Guzman M. The CB1 cannabinoid receptor is coupled to the activation of protein kinase B/Akt. Biochem. J. 347 (2000) 369-373
60. Jobin C., Morteau O., Han D.S., and Balfour Sartor R. Specific NF-kappaB blockade selectively inhibits tumour necrosis factor-alpha-induced COX-2 but not constitutive COX-1 gene expression in HT-29 cells. Immunology 95 (1998) 537-543
61. Wang C.Y., Mayo M.W., Korneluk R.G., Goeddel D.V., and Baldwin Jr. A.S. NF-kappaB antiapoptosis: induction of TRAF1 and TRAF2 and c-IAP1 and c-IAP2 to suppress caspase-8 activation. Science 281 (1998) 1680-1683
62. Wu M.X., Ao Z., Prasad K.V., Wu R., and Schlossman S.F. IEX-1L, an apoptosis inhibitor involved in NF-kappaB-mediated cell survival. Science 281 (1998) 998-1001
63. Guttridge D.C., Albanese C., Reuther J.Y., Pestell R.G., and Baldwin Jr. A.S. NF-kappaB controls cell growth and differentiation through transcriptional regulation of cyclin D1. Mol. Cell. Biol. 19 (1999) 5785-5799
64. Currie R.A., MacLeod B.M., and Downes C.P. The lipid transfer activity of phosphatidylinositol transfer protein is sufficient to account for enhanced phospholipase C activity in turkey erythrocyte ghosts. Curr. Biol. 7 (1997) 184-190
65. Rhee S.G. Regulation of phosphoinositide-specific phospholipase C. Annu. Rev. Biochem. 70 (2001) 281-312
66. Munro S., Thomas K.L., and Abu-Shaar M. Molecular characterization of a peripheral receptor for cannabinoids. Nature 365 (1993) 61-65
67. Matsuda L.A., Lolait S.J., Brownstein M.J., Young A.C., and Bonner T.I. Structure of a cannabinoid receptor and functional expression of the cloned cDNA. Nature 346 (1990) 561-564
68. Wang T., Pentyala S., Elliott J.T., Dowal L., Gupta E., Rebecchi M.J., and Scarlata S. Selective interaction of the C2 domains of phospholipase C-beta1 and -beta2 with activated Galphaq subunits: an alternative function for C2-signaling modules. Proc. Natl. Acad. Sci. U. S. A. 96 (1999) 7843-7846
69. Cunningham E., Tan S.K., Swigart P., Hsuan J., Bankaitis V., and Cockcroft S. The yeast and mammalian isoforms of phosphatidylinositol transfer protein can all restore phospholipase C-mediated inositol lipid signaling in cytosol-depleted RBL-2H3 and HL-60 cells. Proc. Natl. Acad. Sci. U. S. A. 93 (1996) 6589-6593
70. Alonso F., Henson P.M., and Leslie C.C. A cytosolic phospholipase in human neutrophils that hydrolyzes arachidonoyl-containing phosphatidylcholine. Biochim. Biophys. Acta 878 (1986) 273-280